Skip to main content
VCbacked
Log inGet Started

Terns Pharmaceuticals

Foster City, United States

Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.

$650.0M raised
Dec 2025
Post-IPO Equity
BiotechnologyHealth CareMedicalMedical DevicePharmaceutical

Top Investors

Eli LillyVivo CapitalLilly Asia VenturesOrbiMedDecheng Capital

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Terns Pharmaceuticals

How much funding has Terns Pharmaceuticals raised?
Terns Pharmaceuticals has raised $650.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
Who are Terns Pharmaceuticals's investors?
Terns Pharmaceuticals's investors include Eli Lilly, Vivo Capital, Lilly Asia Ventures, OrbiMed, Decheng Capital.
Where is Terns Pharmaceuticals headquartered?
Terns Pharmaceuticals is headquartered in Foster City, United States.
What does Terns Pharmaceuticals do?
Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.
What stage is Terns Pharmaceuticals at?
Terns Pharmaceuticals is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Terns Pharmaceuticals — Funding & Investors." VCBacked, December 9, 2025, https://www.vcbacked.co/company/terns-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2025). Terns Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/terns-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Terns Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/terns-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K